Table 2 Actual (2015–2017) and 5-year projected cost savings from canakinumab vial-sharing

Total number of vials used if no vial sharing^a

268

Total number of vials used with vial sharing^a

151

Total number of vials saved over 24 months^a

117

Cost of one 150 mg canakinumab vial (excluding VAT)

£9927.80

Cost of one 150 mg canakinumab vial (including VAT)

£11,913

Total drug cost without vial sharing^b

£3,192,684

Total drug cost with vial sharing^b

£1,798,863

Cost saving from vial sharing over 24 months (Including preparation cost)

£1,385,821

Projected net cost saving over the next five years^c (Including preparation cost)

£3,464,552.50